Infection by SARS‐CoV‐2 with alternate frequencies of mRNA vaccine boosting
JP Townsend, HB Hassler… - Journal of medical …, 2023 - Wiley Online Library
One of the most consequential unknowns of the COVID‐19 pandemic is the frequency at
which vaccine boosting provides sufficient protection from infection. We quantified the …
which vaccine boosting provides sufficient protection from infection. We quantified the …
Serodominant SARS-CoV-2 Nucleocapsid Peptides Map to Unstructured Protein Regions
JP Vandervaart, NL Inniss, T Ling-Hu… - Microbiology …, 2023 - Am Soc Microbiol
ABSTRACT The SARS-CoV-2 nucleocapsid (N) protein is highly immunogenic, and anti-N
antibodies are commonly used as markers for prior infection. While several studies have …
antibodies are commonly used as markers for prior infection. While several studies have …
Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparison
I Kroidl, S Winter, R Rubio-Acero, A Bakuli… - Virology Journal, 2023 - Springer
Background Measuring specific anti-SARS-CoV-2 antibodies has become one of the main
epidemiological tools to survey the ongoing SARS-CoV-2 pandemic, but also vaccination …
epidemiological tools to survey the ongoing SARS-CoV-2 pandemic, but also vaccination …
Cumulative and undiagnosed SARS-CoV-2 infection among the staff of a medical research centre in Tokyo after the emergence of variants
T Mizoue, S Yamamoto, Y Oshiro, N Inamura… - Epidemiology & …, 2023 - cambridge.org
To describe the trend of cumulative incidence of coronavirus disease 19 (COVID-19) and
undiagnosed cases over the pandemic through the emergence of severe acute respiratory …
undiagnosed cases over the pandemic through the emergence of severe acute respiratory …
Assessment of the biological impact of SARS-CoV-2 genetic variation using an authentic virus neutralisation assay with convalescent plasma, vaccinee sera, and …
NS Coombes, KR Bewley, Y Le Duff, M Hurley… - Viruses, 2023 - mdpi.com
In the summer of 2020, it became clear that the genetic composition of SARS-CoV-2 was
changing rapidly. This was highlighted by the rapid emergence of the D614G mutation at …
changing rapidly. This was highlighted by the rapid emergence of the D614G mutation at …
Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019–2021
H Ratcliffe, KS Tiley, N Andrews… - Archives of disease in …, 2023 - adc.bmj.com
Objective To understand community seroprevalence of SARS-CoV-2 in children and
adolescents. This is vital to understanding the susceptibility of this cohort to COVID-19 and …
adolescents. This is vital to understanding the susceptibility of this cohort to COVID-19 and …
Impact of vaccinations, boosters and lockdowns on COVID-19 waves in French Polynesia
LAC Chapman, M Aubry, N Maset, TW Russell… - Nature …, 2023 - nature.com
Estimating the impact of vaccination and non-pharmaceutical interventions on COVID-19
incidence is complicated by several factors, including successive emergence of SARS-CoV …
incidence is complicated by several factors, including successive emergence of SARS-CoV …
SARS‐CoV‐2 antibody dynamics over time and risk factors associated with infection and long COVID‐19 symptoms in large working environments
CB Hansen, K Dvoncova, L Pérez‐Alós… - Journal of Internal …, 2023 - Wiley Online Library
Abstract Background Factors influencing SARS‐CoV‐2 antibody dynamics, transmission,
waning and long COVID‐19 symptomatology are still not fully understood. Methods In the …
waning and long COVID‐19 symptomatology are still not fully understood. Methods In the …
Evaluation of the neutralising antibody response in human and hamster sera against SARS-CoV-2 variants up to and including BA. 2.86 using an authentic virus …
NS Coombes, KR Bewley, Y Le Duff… - 2023 - europepmc.org
New vaccines, therapeutics and immunity elicited by natural infection create evolutionary
pressure on SARS-CoV-2 to evolve and adapt to evade vaccine-induced and infection …
pressure on SARS-CoV-2 to evolve and adapt to evade vaccine-induced and infection …
Evaluation of the cross reactivity of neutralising antibody response in vaccinated human and convalescent hamster sera against SARS-CoV-2 variants up to and …
NS Coombes, KR Bewley, Y Le Duff… - bioRxiv, 2023 - biorxiv.org
New vaccines, therapeutics and immunity elicited by natural infection create evolutionary
pressure on SARS-CoV-2 to evolve and adapt to evade vaccine-induced and infection …
pressure on SARS-CoV-2 to evolve and adapt to evade vaccine-induced and infection …